Skip to main content
. Author manuscript; available in PMC: 2014 Sep 1.
Published in final edited form as: Nanomedicine (Lond). 2013 Apr 23;8(11):1807–1813. doi: 10.2217/nnm.12.214

Figure 1. Patient interest by timing of injections, respondent demographics and self-reported adherence.

Figure 1

Percentages of respondents who indicated that they definitely would, probably would, probably would not or definitely would not be interested in trying nanoformulated parenteral antiretroviral therapy (A) overall, (B) by age, (C) by race or gender and (D) by level of self-reported adherence. The actual number of respondents to each specific question is included in parentheses.